News about Digitalization

US and European Regulators Set Principles for Responsible AI Use in Drug Development

US and European Regulators Set Principles for Responsible AI Use in Drug Development

US and European medicines regulators have jointly issued a set of guiding principles to support the safe, effective and responsible use of artificial intelligence (AI) in drug development, marking a significant step toward regulatory alignment on emerging technologies.

Digitalization | 15/01/2026 | By Darshana 263

TetraScience, Thermo Fisher Collaborate to Accelerate AI in Biopharma R&D and Manufacturing

TetraScience, Thermo Fisher Collaborate to Accelerate AI in Biopharma R&D and Manufacturing

The partnership between TetraScience and Thermo Fisher aims to transform fragmented scientific data into AI-native workflows, enabling faster, scalable and more efficient drug development and manufacturing.

Digitalization | 13/01/2026 | By News Bureau 396

Experts Highlight Need for AI-Based Quality and Traceability in Medicinal Plants

Experts Highlight Need for AI-Based Quality and Traceability in Medicinal Plants

Experts at a national seminar hosted by IIT Delhi emphasised the need for AI-enabled farm-gate quality assessment and traceability to strengthen India’s medicinal plant supply chain, outlining a digital roadmap to enhance the global competitiveness of AYUSH raw materials.

Digitalization | 13/01/2026 | By News Bureau 216

Sophia Genetics, MD Anderson Partner to Advance AI-Driven Precision Oncology

Sophia Genetics, MD Anderson Partner to Advance AI-Driven Precision Oncology

The strategic collaboration will combine SOPHiA GENETICS’ AI-powered analytics with MD Anderson Cancer Centre’s clinical expertise to develop next-generation sequencing tools and accelerate data-driven cancer diagnosis and treatment.

Digitalization | 12/01/2026 | By News Bureau 210

PharmaForceIQ Strengthens AI Capabilities with Aktana Acquisition

PharmaForceIQ Strengthens AI Capabilities with Aktana Acquisition

PharmaForceIQ, an end-to-end, real-time customer engagement platform for the pharmaceutical industry, has announced the acquisition of Aktana, integrating its digital commercialization platform with Aktana’s artificial intelligence-driven field next-best-action (NBA) technology.

Digitalization | 11/01/2026 | By Darshana 607

Inizio Unveils AI-Enabled Advisory Platform Inizio Ignite to Accelerate Pharma Performance

Inizio Unveils AI-Enabled Advisory Platform Inizio Ignite to Accelerate Pharma Performance

Inizio, a leading global commercialization partner for pharmaceutical and life sciences, unveiled Inizio Ignite, a reimagined and fully integrated advisory partner designed to accelerate pharmaceutical performance through strategy, insights, and innovation.

Digitalization | 09/01/2026 | By Darshana 427

Variant Bio Launches World's First Agentic AI Genomic Drug Discovery Platform

Variant Bio Launches World's First Agentic AI Genomic Drug Discovery Platform

The agentic AI platform by Variant Bio, named Inference, brings together genetic and multi-omic data with autonomous analysis capabilities, and is already powering pharmaceutical partnerships totaling over USD 200 million.

Digitalization | 09/01/2026 | By News Bureau 421

Sectra Enters Japan's Digital Pathology Market with Kameda Medical Centre Project

Sectra Enters Japan's Digital Pathology Market with Kameda Medical Centre Project

Sectra brings AI-enabled digital pathology workflows to Kameda Medical Centre in partnership with Matsunami Glass.

Digitalization | 07/01/2026 | By News Bureau 446

Insilico Medicine and Servier Forge AI-Driven Oncology Drug Discovery Alliance

Insilico Medicine and Servier Forge AI-Driven Oncology Drug Discovery Alliance

Insilico Medicine, a global leader in artificial intelligence–driven drug discovery, has entered into a multi-year research and development collaboration with Servier, an independent international pharmaceutical company governed by a foundation.

Digitalization | 06/01/2026 | By Darshana 131

Revvity Launches AI Platform for Molecular and Materials Discovery

Revvity Launches AI Platform for Molecular and Materials Discovery

Revvity has launched a new AI-powered Models-as-a-Service (MaaS) platform designed to integrate in-silico molecular and materials design with experimental data, enabling continuous learning, improved predictive accuracy, and faster scientific discovery.

Digitalization | 17/12/2025 | By News Bureau 236

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members